Image source: Shutterstock

Highlights

  • Healius shares climb 11.8% to A$1.465, poised for biggest gain since August 21.
  • Year-to-date gains reach ~7%, reversing prior losses of over 4%.
  • Special dividend of 41.3 Australian cents per share to be paid after unit sale.

Shares of Healius (ASX:HLS) surged 11.8% on March 27, reaching A$1.465. This rise was driven by positive financial updates, including a 6.2% year-to-date revenue increase and a 4% jump in volumes for the company’s February results. If these gains hold, Healius is set to achieve its biggest percentage rise in several months.

The healthcare company’s share price surge has propelled its year-to-date gains to approximately 7%, a recovery from the over 4% losses seen at Wednesday’s close. This sharp reversal follows the announcement of solid revenue growth and higher volumes, providing investors with renewed confidence.

In addition to the positive financial performance, Healius also revealed plans to pay a special dividend of 41.3 Australian cents per share. This dividend comes after the company’s decision to sell its diagnostic imaging unit, signaling a further move toward shareholder returns.

Despite these encouraging signs, the company had posted a first-half 2025 net profit after tax (NPAT) loss of A$12.8 million ($8.08 million) last month, which had raised some concerns in the market. However, the latest developments have helped to boost investor sentiment.

With approximately 3.7 million shares changing hands, Healius saw its busiest trading day since March 4. The increased activity reflects growing investor interest as the company continues to navigate a mixed financial landscape. Investors will likely remain focused on future updates, including the impact of strategic decisions and the ongoing market conditions affecting the healthcare sector.